T vs WHWK · P/E 7.4, rev $63.06B vs $202.8M cap
AT&T Inc. (T) versus Whitehawk Therapeutics, Inc. (WHWK) — a side-by-side from cached financials, not a winner call.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Latest reported T revenue for 2026-06-30 was $63.06B. Net income was $8.46B. T currently screens at market cap $155.92B and trailing P/E 7.4.
Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.
T currently screens at market cap $155.92B and trailing P/E 7.4. WHWK currently screens at market cap $202.8M.
Not investment advice. Open the T and WHWK stock pages for the full models.
Not investment advice.